Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2011 08:30 ET | Source: Icagen, Inc.

Icagen Reaffirms Recommendation to Shareholders to Tender Shares

RESEARCH TRIANGLE PARK, N.C., Aug. 29, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has sent the following letter to stockholders affirming the Board's recommendation...
August 16, 2011 08:30 ET | Source: Icagen, Inc.

Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share

RESEARCH TRIANGLE PARK, N.C., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has mailed the following letter to stockholders reiterating its recommendation that...
August 10, 2011 08:30 ET | Source: Icagen, Inc.

Icagen Reports Second Quarter 2011 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the second quarter ended June 30, 2011....
July 20, 2011 08:30 ET | Source: Icagen, Inc.

Pfizer to Acquire Icagen

NEW YORK and RESEARCH TRIANGLE PARK, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE:PFE) and Icagen, Inc. (Nasdaq:ICGN) today announced that they have entered into a definitive merger...
June 24, 2011 17:07 ET | Source: Icagen, Inc.

Icagen Issues Statement in Response to Pfizer SEC Filing

RESEARCH TRIANGLE PARK, N.C., June 24, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) issued today the following statement: In response to the filing of a Schedule 13D today by Pfizer Inc. in...
June 20, 2011 08:00 ET | Source: Icagen, Inc.

Icagen and Pfizer Initiate Nav 1.7 Phase I Multiple Ascending Dose Study

RESEARCH TRIANGLE PARK, N.C., June 20, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders which is being...
May 04, 2011 08:00 ET | Source: Icagen, Inc.

Icagen Reports First Quarter 2011 Financial Results And Operational Highlights

RESEARCH TRIANGLE PARK, N.C., May 4, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2011. For...
May 03, 2011 08:00 ET | Source: Icagen, Inc.

Icagen Forms Collaboration With Yale School of Medicine and Pfizer to Investigate Potential Novel Pain Treatments

RESEARCH TRIANGLE PARK, N.C., May 3, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has entered into a three-party collaboration with the Yale School of Medicine and...
April 25, 2011 16:51 ET | Source: Icagen, Inc.

Icagen Announces Promotion of Dr. Douglas Krafte to Chief Scientific Officer

RESEARCH TRIANGLE PARK, N.C., April 25, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced the promotion of Douglas Krafte, Ph.D. to the newly created position of Chief Scientific...
April 21, 2011 08:30 ET | Source: Icagen, Inc.

Icagen to Report First Quarter 2011 Results on May 4, 2011

RESEARCH TRIANGLE PARK, N.C., April 21, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2011 financial results on Wednesday, May 4, 2011 before the...